Terms: = Brain cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270 AND Prognosis
6 results:
1. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA panel as a molecular biomarker in glioma.
Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
[TBL] [Abstract] [Full Text] [Related]
3. The lncRNA hoxa11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract] [Full Text] [Related]
4. Underexpression of hoxa11 Is Associated with Treatment Resistance and Poor prognosis in Glioblastoma.
Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
[TBL] [Abstract] [Full Text] [Related]
5. A novel cell cycle-associated lncRNA, hoxa11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
[TBL] [Abstract] [Full Text] [Related]
6. Promoter methylation of AREG, hoxa11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.
Skiriutė D; Vaitkienė P; Ašmonienė V; Steponaitis G; Deltuva VP; Tamašauskas A
J Neurooncol; 2013 Jul; 113(3):441-9. PubMed ID: 23624749
[TBL] [Abstract] [Full Text] [Related]
